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CanadaA B S T R A C TBackground: Economic evaluations provide a unique opportunity to
identify the optimal strategies for the diagnosis and management of
traumatic brain injury (TBI), for which uncertainty is common and the
economic burden is substantial. Objective: The objective of this study
was to systematically review and examine the quality of contempo-
rary economic evaluations in the diagnosis and management of TBI.
Methods: Two reviewers independently searched MEDLINE, EMBASE,
Cochrane Central Register of Controlled Trials, NHS Economic Evalua-
tion Database, Health Technology Assessment Database, EconLit, and
the Tufts CEA Registry for comparative economic evaluations pub-
lished from 2000 onward (last updated on August 30, 2013). Data on
methods, results, and quality were abstracted in duplicate. The results
were summarized quantitatively and qualitatively. Results: Of 3539
citations, 24 economic evaluations met our inclusion criteria. Nine
were cost-utility, ﬁve were cost-effectiveness, three were cost-mini-
mization, and seven were cost-consequences analyses. Only sixee front matter Copyright & 2015, International S
r Inc.
.1016/j.jval.2015.04.012
@mail.utoronto.ca.
ndence to: Aziz S. Alali, Institute of Health Policy,
a M4N 3M5.studies were of high quality. Current evidence from high-quality
studies suggests the economic attractiveness of the following strat-
egies: a low medical threshold for computed tomography (CT) scan-
ning of asymptomatic infants with possible inﬂicted TBI, selective CT
scanning of adults with mild TBI as per the Canadian CT Head Rule,
management of severe TBI according to the Brain Trauma Foundation
guidelines, management of TBI in dedicated neurocritical care units,
and early transfer of patients with TBI with nonsurgical lesions to
neuroscience centers. Conclusions: Threshold-guided CT scanning,
adherence to Brain Trauma Foundation guidelines, and care for
patients with TBI, including those with nonsurgical lesions, in speci-
alized settings appear to be economically attractive strategies.
Keywords: cost-beneﬁt analysis, cost-effectiveness, cost utility,
economic evaluation, systematic review, traumatic brain injury.
Copyright & 2015, International Society for Pharmacoeconomics and
Outcomes Research (ISPOR). Published by Elsevier Inc.Introduction
Traumatic brain injury (TBI) presents a major economic, social,
and health challenge worldwide [1]. According to the World
Health Organization, TBI will surpass many diseases as the major
cause of death and disability by 2020 [2]. In the United States,
53,000 individuals die annually from TBIs, and at least 5.3 million
Americans are currently living with long-term disabilities directly
attributable to TBI [3,4]. In 2010, the estimated overall burden of
TBI on the US economy was approximately $76.5 billion, with
costs for disability and lost productivity outweighing those foracute medical care and rehabilitation [5,6]. Despite the profound
consequences of TBI, there is substantial uncertainty surround-
ing the costs and beneﬁts of several alternative diagnostic and
therapeutic strategies from the societal and health care system
perspectives [7,8].
Economic evaluations are tools to weigh the relative costs and
beneﬁts of alternative courses of action [9]. They provide means
to support decision making in a cost-constrained environment of
health care and can be used to explore areas of uncertainty in
both costs and beneﬁts. Without considering economic data, the
allocation of resources may not lead to optimal value for healthociety for Pharmacoeconomics and Outcomes Research (ISPOR).
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V A L U E I N H E A L T H 1 8 ( 2 0 1 5 ) 7 2 1 – 7 3 4722care spending. Therefore, economic evaluations provide a unique
opportunity to identify the optimal strategies for the diagnosis
and management of TBI, for which uncertainty is common and
the consequential economic burden on patients and health care
system is substantial [1,7,10]. Inadequately informed, designed,
or poorly executed economic evaluations, however, may ill-
inform resource allocation and lead to poor health policy deci-
sions [9].
In this context, we systematically reviewed and evaluated the
quality of economic evaluations in the diagnosis and manage-
ment of TBI.Methods
Search Methods
We duplicate searched the following databases: MEDLINE,
EMBASE, NHS Economic Evaluation Database, Health Technology
Assessment Database, EconLit, Tufts CEA Registry, and Cochrane
Central Register of Controlled Trials. The search retrieved articles
published between January 1, 2000, and August 30, 2013. We
followed published guidelines on EMBASE searches for economic
studies [11]. We also searched the reference lists of relevant
studies, and the Web sites of health technology assessment
agencies, including the Canadian Agency for Drugs and Tech-
nologies in Health and the National Institute for Health Research
Health Technology Assessment program. The search was not
restricted by language. We did not consider conference abstracts
or unpublished data. The full text of any cited article that was
considered potentially relevant was retrieved. The search strat-
egies are described in detail in the Appendix in Supplementary
Materials found at http://dx.doi.org/10.1016/j.jval.2015.04.012.Study Selection
Type of studies
We included published comparative economic evaluations. The
search was limited to the literature published from 2000 onward,
to focus on contemporary studies that are potentially relevant to
the current economic environment. Furthermore, older studies
are likely to derive their input values from outdated clinical
effectiveness and cost-estimation data. We included both single
study–based (i.e., clinical data were derived from a single study)
and model-based (i.e., incorporating clinical data from various
sources) economic evaluations.Type of patients
Economic evaluations related to patients of any age who had
mild, moderate, and/or severe TBI were included. Studies that
included general trauma patients or those with acquired brain
injury were included only if a subgroup analysis on patients with
TBI was reported.Type of comparators
We included economic evaluations of any diagnostic modality,
medical, or surgical intervention aimed at the diagnosis and/or
management of patients with TBI.
We scanned the abstracts of every record retrieved to deter-
mine which studies should be further assessed. If it was clear
from the abstract that the article was irrelevant, we rejected the
record. The full texts of the remaining articles were evaluated.
Two reviewers (A.A. and K.B.) independently assessed and deter-
mined the eligibility of each study. Disagreements were resolved
by discussion and consensus.Data Extraction
Data abstraction forms were created to collect the relevant data
from the included studies (see Appendix in Supplemental
Material). Two review authors (A.A. and K.B.) independently
extracted the data on target population, comparators, methods,
outcomes, and results using a data extraction form (see Appendix
in Supplemental Material). Any discrepancy in data extraction
was resolved by discussion and consensus. We divided the
economic evaluations into ﬁve groups as deﬁned by Drummond
et al. [9]: cost-utility analyses, cost-effectiveness analyses,
cost-beneﬁt analyses, cost-minimization analyses, and cost-
consequences analyses. To facilitate comparison, costs were
converted, if price date and currency were speciﬁed, to 2012
international dollars (Geary-Khamis dollars) using the World
Bank’s purchasing power parity conversion factors, after adjust-
ing for temporal changes in country-speciﬁc gross domestic
product [12,13]. The international dollar (Int.$) is a hypothetical
unit of currency that has the same purchasing power parity (i.e.,
same ability to buy the same amount of goods and services) that
US dollar had in the United States at a given point in time [14].
Assessment of Methodological Quality
Two review authors (A.A. and K.B.) independently assessed the
quality of each included study using the 24-item Consolidated Health
Economic Evaluation Reporting Standards checklist [15,16]. Quality
scores were assigned on the basis of this checklist (range 0–24 points).
Any disagreement was resolved by discussion and consensus.
The results of all economic evaluations that met our eligibility
criteria were summarized qualitatively and quantitatively
(Tables 1–3). Studies of high quality (quality score4 20/24 [480%])
were discussed in more detail.Results
Results of the Search
Our search strategy yielded a total of 4079 potentially relevant
citations; 540 duplicates were excluded, and 3465 were excluded
after scanning the abstracts because they did not meet our
inclusion criteria (Fig. 1). A total of 74 citations were retrieved
for detailed evaluation of full-text articles. Fifty of these articles
were excluded because they did not meet our inclusion criteria
(further details are available in the Appendix in Supplemental
Material). Common reasons for exclusion were lack of compara-
tor, combining data from patients with TBI and other causes of
acquired brain injury (e.g., stroke) in the analysis, and reporting
hospital charges (rather than costs) only.
Description of Included Studies
Twenty-four economic evaluations met the inclusion criteria.
Nine studies were cost-utility analyses [17–25], ﬁve were cost-
effectiveness analyses [26–30], three were cost-minimization
analyses [31–33], and seven were cost-consequences analyses
[34–40]. There were no cost-beneﬁt analyses that met our inclu-
sion criteria.
Tables 1, 2, and 3 summarize the characteristics and ﬁndings
of economic evaluations of diagnostic approaches, management
strategies, and alternative structures of care, respectively, for
patients with TBI. Further details are provided in the Appendix in
Supplemental Material. Seven studies examined diagnostic strat-
egies for mild TBI in children and/or adults [20–22,26,31,33,40],
two compared different screening strategies for suspected blunt
cerebrovascular injury [24,27], two evaluated management strat-
egies for patients with mild TBI [20,23], and four studies
Table 1 – Economic evaluations of diagnostic strategies.
Study Design Population Setting Perspective
(currency)
Comparators Time horizon Incremental costs
and outcomes
Quality
score
Af Geijerstam
et al. [31]
Model-based
cost-
minimization
analysis
Patients with mild
TBI; age was not
speciﬁed
Swedish Health
Care System
Not speciﬁed
(1998 pound
sterling)
CT scan and home
care strategy vs.
in-hospital
observation
2 d 36% reduction in cost
with CT strategy
(£300 vs. £470 [Int.
$612 vs. 959])
15/24
Campbell
et al. [26]
Model-based
cost-
effectiveness
analysis
Asymptomatic 5-wk-
old infant with
either 1)
unexplained scalp
bruising or 2) a
history of an
apparent life-
threatening event
(ALTE)
ED. Location was
not speciﬁed
Medical payer
and societal
(2005 US
dollars)
CT head on
presentation vs.
discharge from
hospital with no
CT scan
Until age 52 wk
or death
From the medical
payer perspective,
the CT strategy
saves $3880 (Int.
$4500) for every
severe/fatal inﬂicted
TBI averted in the
scalp-bruising
scenario while CT
costs $72,744 (Int.
$84,368) per case
averted in the ALTE
scenario. From the
societal perspective,
CT costs $132,701
(Int.$153,907) and
$209,328 (Int.
$242,779) per case
averted for bruising
and ALTE scenarios,
respectively
22/24
Kaye et al.
[27]
Model-based
cost-
effectiveness
analysis
Adults with
suspected blunt
cerebrovascular
injury (based on
predeﬁned
criteria)
Not speciﬁed Institutional and
societal (2008
US dollars)
No screening, duplex
ultrasound,
magnetic
resonance
angiography,
catheter
angiography, and
CT angiography
(CTA)
Not speciﬁed From the societal
perspective, CTA
was the dominant
strategy ($3727 [Int.
$3983] per patient
with 1% stroke rate).
From the
institutional
perspective, duplex
ultrasound and CTA
were the most cost-
effective screening
modalities, with a
cost of $8940 (Int.
$9554) and $10,670
(Int.$11,402) per
stroke prevented,
respectively
17/24
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Table 1 – continued
Study Design Population Setting Perspective
(currency)
Comparators Time horizon Incremental costs
and outcomes
Quality
score
Norlund et al.
[40]
Single study–
based cost-
consequences
analysis (a
multicenter
RCT; n ¼ 2602)
Patients with mild
TBI (aged Z6 y)
Acute hospitals
in Sweden
Societal (2003
euros)
Immediate CT
during triage for
admission vs.
observation in
hospital
3 mo Clinical outcomes
were similar for
both groups. The
total average cost
was €718 (Int.$1034)
per patient for the
CT group vs. €914
(Int.$1316) per
patient for the
observation group, a
difference of €196
(Int.$282)
19/24
Pandor et al.
[20]
Model-based
cost-utility
analysis
Patients with mild
TBI aged 1, 10, 40
and 75 y,
presenting to the
ED
EDs in the United
Kingdom
The NHS and the
PSS in England
and Wales
(pound
sterling; price
date not
speciﬁed)
Diagnostic strategies
for mild TBI in
children and
adults (CT all,
selective CT
scanning using
multiple decision
rules, no CT)
Lifetime 1. For children aged 1 or
10 y, the CHALICE rule
dominates the other
strategies by virtue of
gaining more QALYs
(mean 22.41) with
lower costs (mean
£3567)
2. For adults aged 40 y,
the CCHRhm strategy
had an ICER of £3879/
QALY when
compared with the
Scandinavian
strategy. All other
strategies were either
dominated or
extendedly
dominated. For adults
aged 75 y, the
CCHRhm strategy had
an ICER of £10,397/
QALY when
compared with the
Scandinavian
strategy. All other
strategies were
dominated
continued on next page
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Ruan et al.
[33]
Model-based
cost-
minimization
analysis
Adults with mild TBI ED. Location was
not speciﬁed
Hospital (US
dollars; price
date not
speciﬁed)
Screening with
serum S100B,
followed by CT
head only if the
S100B is abnormal
(40.1 μg/L) vs.
ordering CT head
at the discretion
of the ED
physician based
on presenting
symptoms
2 d S-100B as a screen test
would cost
hospitals on
average $281 per
patient, whereas
selective CT
scanning based on
physician discretion
would cost on
average $160 per
patient
16/24
Smits et al.
[21]
Single study–
based cost-
utility analysis
(prospective
multicenter
cohort study;
n ¼ 3181)
Adults with mild TBI Dutch university
hospital
Societal (2006 US
dollars)
Diagnostic strategies
for mild TBI in
adults (CT all,
selective CT
scanning using
multiple decision
rules, no CT)
Lifetime All CT strategies were
almost equally
effective (22.464
QALYs). The CCHR
was the least costly
(lifetime cost $8800
[Int.$9889]) and thus
the most cost-
effective
23/24
Stein et al.
[22]
Model-based
cost-utility
analysis
Adults with mild TBI Not speciﬁed Health care
payer* (2005 US
dollars)
Diagnostic strategies
for mild TBI in
adults (CT all,
selective CT as per
CCHR, observation
in ED, admission,
skull x-ray)
Lifetime Use of the CCHR and
the CT All strategies
yields the greatest
number of QALYs
(28.85 QALY). The
CCHR strategy had
the lowest expected
total cost ($1668
[Int.$1935]),
followed by the CT
All strategy ($1888
[Int.$2190])
19/24
Wang et al.
[24]
Single study–
based cost-
utility analysis
(retrospective
single-center
cohort study;
n ¼ 222)
Adults with
suspected blunt
cerebrovascular
injury (based on
predeﬁned
criteria)
Level 1 trauma
center, Ann
Arbor, MI
Not speciﬁed (US
dollars; price
date not
speciﬁed)
CTA vs. catheter-
based digital
subtraction
angiography (DSA)
30 y The ICER for DSA is
$3199/QALY
13/24
CCHR, Canadian CT Head Rule; CCHRh, Canadian CT Head Rule high risk; CCHRhm, Canadian CT Head Rule high or medium risk; CHALICE, Children’s Head injury Algorithm for the prediction
of Important Clinical Events; ED, emergency department; ICER, incremental cost-effectiveness ratio; Int.$, 2012 international dollar (Geary-Khamis dollar); NHS, National Health Service; PSS,
personal social services; QALY, quality-adjusted life-year; RCT, randomized controlled trial; TBI, traumatic brain injury.
* The study was described as of societal perspective. However, productivity loss and indirect health care expenses were not taken into account.
V
A
L
U
E
IN
H
E
A
L
T
H
1
8
(2
0
1
5
)
7
2
1
–
7
3
4
725
Table 2 – Economic evaluations of management strategies.
Study Design Population Setting Perspective
(currency)
Comparators Time horizon Incremental costs and
outcomes
Quality
score
Cotton et al.
[17]
Model-based cost-
utility analysis
Patients with TBI; age
was not speciﬁed
Level I trauma
center. Location
was not
speciﬁed
Not speciﬁed (US
dollars; price
date not
speciﬁed)
Phenytoin vs.
levetiracetam for
posttraumatic
seizure prophylaxis
Not speciﬁed Levetiracetam strategy (23.2
QALY, $480) was
dominated by the
phenytoin strategy (23.6
QALY, $37.5)
13/24
Faul et al. [30] Model-based cost-
effectiveness
analysis
Patients with severe
TBI (age Z12 y)
Nonfederal short-
stay hospital in
the United
States
Not speciﬁed (2002
US dollars)
33% compliance rate
with BTF guidelines
for the treatment of
severe TBI (current
state) vs. increasing
the compliance rate
to 80% (widespread
adoption of BTF
guidelines)
Not speciﬁed 3607 lives and $4.08 billion
(Int.$5.13 billion) would be
saved every year with
widespread adoption of
BTF guidelines
15/24
Ho et al. [19] Single study–based
cost-utility analysis
(retrospective
single-center case
series; n ¼ 168)
Adult patients with
TBI who need
decompressive
craniectomy (DC) as
a life-saving
procedure including
those with
bilaterally
uncreative pupils
Two neurotrauma
centers in
Western
Australia
Societal (2011–
2012 US dollars)
DC (unilateral or
bilateral) as a life-
saving procedure
vs. withholding
surgery and
withdrawal of life
support
Lifetime For patients with 480% risk
of an unfavorable
outcome, the ICER for DC
was $682,000/QALY (Int.
$698,368/QALY). For
patients with r80%
predicted risk of an
unfavorable outcome, the
ICER was $140,000/QALY
(Int.$143,360/QALY)
16/24
Ibrahim et al.
[34]
Model-based cost-
consequences
analysis
Adults with severe TBI The
neurointensive
care unit at
Hospital
Universiti Sains,
Malaysia
Not speciﬁed (2002
US dollars)
Intracranial pressure
monitoring alone
(BNM) vs.
multimodality
monitoring
6 mo Mean total provider cost was
$8023.78 (Int.$10,090) and
$9022.63 (Int.$11,336) in
the BNM and M3 groups,
respectively (P ¼ 0.49).
There was a statistically
signiﬁcant difference in
the mean Barthel Index
score (P ¼ 0.031) in favor
of the M3 strategy.
Differences in outcome
persisted after adjusted
analysis
15/24
(M3) strategy
(transcranial
Doppler
ultrasonography,
jugular venous
oximetery, cerebral
oxygen monitoring)
Joseph et al.
[35]
Single study–based
cost-consequences
analysis
(retrospective
single-center cohort
study; n ¼ 85)
Adults with TBI and
induced or acquired
coagulopathy
Level 1 trauma
center, Arizona
Not speciﬁed (US
dollars; price
date not
speciﬁed)
Prothrombin complex
concentrate (PCC)
vs. recombinant
factor VII (rFVIIa)
Not speciﬁed The overall mortality rate
was lower in the patient
group that received PCC
(47%) compared with the
mortality rate in the
patient groups receiving
factor VIIa (67%; P ¼ 0.03).
Mean hospital cost was
signiﬁcantly higher in the
rFVIIa-treated group than
in patients who received
PCC ($62,491 vs. $31,694;
P o 0.01)
9/24
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Pandor et al.
[20]
Model-based cost-
utility analysis
Adults with mild TBI EDs in the United
Kingdom
The NHS and the
PSS in England
and Wales
(pound sterling;
price date not
speciﬁed)
Admission strategies
for adults with mild
TBI
Lifetime 1. Hospital admission for
patients with a normal CT
scan compared with
discharge home with a
responsible adult has an ICER
of £39 million/QALY
2. Hospital admission for
patients with a normal CT
scan compared with
discharge home without a
responsible adult has an
ICER of £2.5 million/QALY
3. The admission strategy for
those with a
nonneurosurgical lesion
costs approximately £340
less and gains 0.004 QALYs
compared with discharge
home and therefore
dominates discharge home
23/24
Pieracci et al.
[32]
Model-based cost-
minimization
analysis
Patients with TBI; age
was not speciﬁed
Not speciﬁed Acute care
institution (2011
US dollars)
Phenytoin vs.
levetiracetam for
posttraumatic
seizure prophylaxis
Acute
hospitalization
period
Phenytoin was more cost
saving with a mean cost
per patient of $151.24 (Int.
$155) when compared
with $411.85 (Int.$422) for
levetiracetam
14/24
Schoenberg
et al. [37]
Model-based cost-
consequences
analysis
Patients who
sustained moderate
to severe TBI at
least 1 y ago; age
was not speciﬁed
Rehabilitation
Hospital,
Oklahoma
Not speciﬁed (US
dollars; price
date not
speciﬁed)
Internet-based
cognitive
rehabilitation
teletherapy
program
(intervention) vs.
face-to-face
outpatient speech–
language therapy
(control)
Not speciﬁed There was no difference
between the two groups in
return to independent
living, work, and school.
The mean total cost per
patient in the intervention
group was not
signiﬁcantly different
from that in the control
group ($3672 vs. $2610;
P ¼ 0.23)
10/24
Stein et al. [23] Model-based cost-
utility analysis
Adults with mild TBI
who have an
intracranial
abnormality on
CT scan that
does not need
surgical
intervention
Not speciﬁed Health care payer*
(US dollars;
price date not
speciﬁed)
Routine follow-up CT
scanning vs.
repeating the CT
scan only in case of
clinical
deterioration
Lifetime The ICER for routine CT
strategy is $12,670/QALY
18/24
Stein et al.
[38]
Single study–based
cost-consequences
analysis
(retrospective
single-center cohort
study;
n ¼ 179)
Patients with TBI and
induced or acquired
coagulopathy; age
was not speciﬁed
Level I trauma
center,
Maryland
Not speciﬁed (US
dollars; price
date not
speciﬁed)
Recombinant factor
VIIa (rFVIIa) vs.
conventional
therapy for
coagulopathy (fresh
frozen plasma and
vitamin K) that does
not include rFV11a.
Dosing regimen was
not speciﬁed
Not speciﬁed Mortality, ICU LOS, and
hospital LOS were the
same in both groups, but
among survivors,
discharge GCS score and
RLAS were higher in
conventionally treated
patients. Total hospital
cost was similar for the
two groups
13/24
continued on next page
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V A L U E I N H E A L T H 1 8 ( 2 0 1 5 ) 7 2 1 – 7 3 4728examined severe TBI management strategies [19,25,30,34]. Two
studies compared management options for coagulopathy in
patients with TBI [35,38], and two studies compared alternative
regimens for posttraumatic seizure prophylaxis [17,32].
Prehospital and in-hospital alternative structures of care for
TBI were examined by four economic evaluations [28,29,36,39].
Only one study [37] examined the economic impact of different
rehabilitation pathways for patients with moderate to severe TBI.
Thirteen economic evaluations were single study–based. Spe-
ciﬁcally, the input values were derived from a randomized
controlled trial (RCT) in two studies [39,40], a subgroup analysis
of an RCT in one study [28], a prospective cohort in two studies
[18,21], and a retrospective single-center cohort/case series in
eight studies [19,24,29,34–38]. The other studies (n ¼ 11) were
model-based, in which the input values were derived from
multiple observational studies (none of the source studies was
an RCT) [17,20–23,25–27,30–33].
Two studies were published during the period 2000 to 2005
[31,36], whereas the remaining 22 were published from 2006 to
August 2013 [17–30,32–35,37–40].
Quality Assessment of Included Studies
The quality scores of the studies ranged between 9 and 23 out of a
total of 24 points (see Tables 1–3 and Appendix in Supplemental
Material). Most of the studies were of low to moderate quality
(n ¼ 18; scores between 9 and 19). Only six studies were considered
to be of high quality (score 4 20/24 [480%]) [18,20,21,25,26,29].
Common methodological shortcomings included failure to spec-
ify a study perspective (n¼ 12) [17,22–24,30,31,34–39], clinical setting/
location (n ¼ 8) [17,22,23,25–27,32,33], time horizon of the analysis
(n ¼ 8) [17,27,30,35–39], price date (n ¼ 8) [17,20,23,24,33,35,37,38],
and/or the funding source (n ¼ 12) [17,19,22–24,27,29,30,32,35–37].
Only seven studies discounted future outcomes/costs [18,20–
23,25,29], whereas none of the studies that used discrete-time,
health state transition models (n ¼ 14) addressed the issue of half-
cycle correction during analysis [17,20–27,29–33]. Twelve studies did
not provide a statement on potential conﬂict of interest [17,19,22,23,
27,28,30,31,34,36,38,39]. Only eight studies considered a lifetime
horizon [18–23,25,29].
Among cost-utility studies (n ¼ 9), four studies [19,22,23,25]
derived their utility scores for the Glasgow Outcome Scale (GOS)
categories from Aoki et al. [41]. Two studies [20,21] used utility
scores provided by Smits et al. [21] cohort. Harrison et al. [18]
prospectively measured the quality of life of patients with TBI at
6 months postinjury using the EuroQol ﬁve-dimensional ques-
tionnaire (the questionnaire was completed by 49% and 48% of
the survivors in the intensive care unit cohort and the transfer
cohort, respectively), and the results were converted to utility
scores to include in their cost-utility analysis. Two studies
mentioned that their utility estimates were obtained from the
literature, but the source was not speciﬁed [17,24]. None of the
included studies considered utility scores for short-term health
states (i.e., health states during the ﬁrst 6 months postinjury, e.g.,
utility score for acute hospitalization period or disutility of a
surgical intervention).
Contrary to ﬁndings from previous studies [42,43], most of the
cost-utility studies (n ¼ 7) assumed that functional outcomes were
ﬁxed after the ﬁrst 6 to 18 months following TBI [17,19,21–23,25].
Results of High-Quality Studies
Economic evaluations of diagnostic strategies
One study estimated the cost-effectiveness of a policy of com-
puted tomography (CT) scanning of the head for inﬂicted TBI
(i.e., brain damage due to violence caused by another person)
in selected asymptomatic infants seen in the emergency
Table 3 – Economic evaluations of structure of care.
Study Design Population Setting Perspective
(currency)
Comparators Time horizon Incremental costs
and outcomes
Quality
score
Harrison et al.
[18]
Single study–
based cost-
utility analysis
(prospective
multicenter
cohort study;
n ¼ 2975)
Adults with TBI
admitted to ICU
Adult ICUs in the
United
Kingdom
The NHS and
the PSS in
England and
Wales (2010–
2011 pound
sterling)
Management in a
dedicated
neurocritical care
unit compared
with a combined
neuro/general
critical care unit
for adult patients
with TBI
presenting at a
neuroscience
center
Lifetime Dedicated neurocritical
care units had higher
mean lifetime QALYs
(9.99 vs. 9.49) at
small additional
mean costs (£34,909
vs. 31,007), with an
ICER of
approximately
£14,000/QALY (Int.
$21,509/QALY)
22/24
Harrison et al.
[18]
Single study–
based cost-
utility analysis
(prospective
multicenter
cohort study;
n ¼ 2975)
Adults with TBI who
initially present at
a nonneuroscience
center and do not
require surgery for
evacuation of a
mass lesion
Neuroscience
centers in the
United
Kingdom
The NHS and
the PSS in
England and
Wales (2010–
2011 pound
sterling)
“Early” (within 18 h
of hospital
presentation)
transfer to a
neuroscience
center compared
with “no or late”
(after 24 h)
transfer
Lifetime The “Early” transfer
group has higher
mean lifetime QALYs
(11.55 vs. 7.19) at an
additional mean cost
(£36,422 vs. 16,105)
with an ICER of
£11,000/QALY (Int.
$16,900/QALY)
22/24
Macnab et al.
[36]
Single study–
based cost-
consequences
analysis
(retrospective
single-center
cohort study;
n ¼ 43)
Children with TBI
transported by air
ambulance to a
tertiary care
facility from
another facility
Provincial air
ambulance
service,
Vancouver, BC,
Canada
Not speciﬁed
(1988 US
dollars)
Transportation by
trained pediatric
transport
personnel vs.
transportation by
personnel (from
the referring
hospital) without
specialized
transport training
as escorts
Not speciﬁed There were 13 adverse
events in six patients
(55%) in the
untrained transport
group and 5 adverse
events in four
patients (12%) in the
trained transport
group (P o 0.05).
The calculated
additional cost of
care resulting from
the adverse events
occurring during
transport by
untrained team is
$12,300 (Int.$21,277)
per patient
transported
9/24
continued on next page
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Table 3 – continued
Study Design Population Setting Perspective
(currency)
Comparators Time horizon Incremental costs
and outcomes
Quality
score
Saltzherr
et al. [28]
Single study–
based cost-
effectiveness
analysis
(subgroup
analysis of an
RCT; n ¼ 120)
Adults with severe
TBI
Level 1 trauma
centers,
Amsterdam,
The
Netherlands
Health care
provider
(2007 euros)
Mobile 4-slice CT
scanner in the
trauma room
(intervention) vs.
64-slice CT
scanner in the
radiology
department
(control)
1 y No signiﬁcant
difference in mean
noninstitutionalized
days alive or costs
15/24
Taylor et al.
[29]
Single study–
based cost-
effectiveness
analysis
(retrospective
single-center
cohort study; n
¼ 1067)
Adult with TBI
(deﬁned as head
AIS score of Z3)
Major trauma
center,
Australia
Health care
provider
(2010
Australian
dollars)
Direct transfer from
the scene to Level
I trauma center
via Physician-
staffed Helicopter
Emergency
Medical Services
(HEMS) vs. ground
ambulance or
indirect transport
(via a referral
hospital)
Lifetime The mean life
expectancy for the
HEMS strategy was
higher (15.3 vs. 14.6
y). The incremental
cost of the HEMS
strategy is Au
$49,159 (Int.$36,296)
per life saved
20/24
Wong et al.
[39]
Single study–
based cost-
consequences
analysis
(single-center
RCT; n ¼ 179)
Patients with TBI; age
was not speciﬁed
Conducted
between a
district general
hospital and a
tertiary
neurosurgical
center, Hong
Kong, China
Not speciﬁed
(2001 Hong
Kong dollars)
Three modes of
neurosurgical
consultation:
Lifetime No signiﬁcant
difference between
the different
consultation
methods in GOS at 6
mo. Cost per patient
was similar for all
consultation
methods
11/24
1. Telephone
consultation
2. Teleradiology
3. Video consultation
AIS, Abbreviated Injury Scale; GOS, Glasgow Outcome Scale; ICER, incremental cost-effectiveness ratio; ICU, intensive care unit; Int.$, 2012 international dollar (Geary-Khamis dollar); NHS,
National Health Service; PSS, personal social services; QALY, quality-adjusted life-year; RCT, randomized controlled trial; TBI, traumatic brain injury.
V
A
L
U
E
IN
H
E
A
L
T
H
1
8
(2
0
1
5
)
7
2
1
–
7
3
4
730
Fig. 1 – Flow chart of study selection process.
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strategy was less costly in the unexplained scalp-bruising sce-
nario (US $3880 [Int.$4,500] saved for every severe/fatal TBI
averted), but cost US $72,744 (Int.$84,368) per case averted in
the apparent life-threatening event scenario [26]. When a societal
perspective was adopted (i.e., adding the costs of child protective
services to the overall cost calculation), the CT scanning strategy
cost US $132,701 (Int.$153,907) and US $209,328 (Int.$242,779) per
case averted for bruising and apparent life-threatening event
scenarios, respectively [26].
Two high-quality cost-utility studies compared diagnostic
strategies for mild TBI in two health care systems (from the
United Kingdom National Health Service [UK NHS] perspective
and from the Dutch societal perspective) [20,21]. Both found that
using the widely validated Canadian CT Head Rule is likely the
most cost-effective diagnostic imaging strategy in adults (Table 1)
[20,21]. In children, Pandor et al. [20] found that the Children’s
Head injury Algorithm for the prediction of Important Clinical
Events (CHALICE) was the dominant strategy at all willingness-
to-pay threshold values, from the UK NHS perspective. In addi-
tion, the authors found that hospital admission dominated (i.e.,
less costly and more effective) discharge home for adults with
mild TBI and nonsurgical lesions, but the admission strategy
costs £39 million/quality-adjusted life-year (QALY) for clinically
normal patients with a normal head CT [20].
Economic evaluations of management strategies
In a cost-utility analysis of compliance with the Brain Trauma
Foundation (BTF) guidelines for the management of severe TBI,
“aggressive care” (deﬁned as a compliance rate of 450%) for
adults with severe TBI was found to be the dominant strategy (i.
e., less costly and more effective) from a US societal perspective
when compared with “routine care” (i.e., compliance with BTF
guidelineso50%) and “comfort care” (i.e., 1 day of aggressive care
in the intensive care unit followed by transfer to a medical-
surgical ﬂoor) [25]. The ﬁndings were consistent when the
patient’s age was assumed to be 40 or 60 years (instead of the
base-case age of 20 years) [25]. For age 80 years, the incremental
cost-effectiveness ratio for aggressive versus routine care was US
$88,507 (Int.$90,631)/QALY [25].
Economic evaluations of structure of care
Using data from a large prospective cohort study (n ¼ 2975),
Harrison et al. [18] found that managing patients with TBI in adedicated neurocritical care unit compared with a general critical
care unit resulted in higher mean QALYs at a small additional
cost, with an incremental cost-effectiveness ratio of £14,000 (Int.
$21,509)/QALY from the UK NHS perspective. There was consid-
erable statistical uncertainty; however, the probability that dedi-
cated compared with general intensive care units are more cost-
effective was approximately 60% on the cost-effectiveness
acceptability curve at a willingness-to-pay threshold of £20,000/
QALY [18]. In addition, the authors found that “early” transfer
(within 18 hours of presentation) of patients with TBI with
nonsurgical lesions to a neuroscience center may be more cost-
effective compared with no or “late” transfers (after 24 hours) at
an incremental cost-effectiveness ratio of £11,000 (Int.$16,900)/
QALY, with a probability close to 100% on the cost-effectiveness
acceptability curve at a willingness-to-pay threshold of £20,000
[18]. Subgroup analyses suggested that early transfer had a very
low probability (20%) of being cost-effective for patients older
than 70 years and a low probability (60%) of being cost-effective
for patients without major extracranial injury [18]. Early transfer
was relatively cost-effective for patients within different TBI
severity subgroups, particularly for severe TBI [18].
Based on a retrospective single-center cohort study (n ¼ 1067)
from Australia, direct transfer of adults with signiﬁcant TBI
(deﬁned as a head Abbreviated Injury Scale score of 43) from
the scene to a Level I trauma center by Physician-staffed Heli-
copter Emergency Medical Services compared with ground ambu-
lance or indirect transport (via a referral hospital) resulted in a
higher mean life expectancy (15.3 vs. 14.6) at an incremental cost
of Au $49,159 (Int.$36,296) per life saved [29].Discussion
We conducted a comprehensive systematic review of the liter-
ature to identify published economic analyses of diagnostic and
management approaches for patients with TBI. Current evidence
from high-quality studies supports the economic attractiveness
of a low medical threshold for CT scanning of asymptomatic
infants with possible inﬂicted TBI, the utilization of the Canadian
CT Head Rule in adults and the CHALICE rule in children as the
diagnostic strategies for mild TBI, the management of adults with
severe TBI according to the BTF guidelines, the management of
TBI in dedicated neurocritical care units instead of combined
critical care units, and the early transfer of patients with TBI with
nonsurgical lesions to neuroscience centers.
Although these ﬁndings were demonstrated in high-quality
economic evaluations, certain methodological deﬁciencies
remained in each study. In estimating the cost-effectiveness of
CT scanning for inﬂicted TBI from a societal perspective, the
short time horizon of cost calculation (52 weeks) may have led to
underestimating the long-term impact of missed TBI in infants,
and therefore may have biased the results against the CT
scanning strategy [26]. In studies of alternative diagnostic strat-
egies for mild TBI, the CHALICE rule has limited validation
outside its derivation cohort, and the results were based on
sensitivity and speciﬁcity estimates obtained from the derivation
cohort [20]. In addition, the generalizability of these studies’
ﬁndings to patients with mild TBI who have induced or acquired
coagulopathy is uncertain because the source of outcome data
was studies that excluded these patients [20]. In the economic
evaluation of different rates of compliance with BTF guidelines
[25], the probability estimates of long-term outcomes for each
strategy were based on pooled data from multiple observational
studies conducted between 1970 and 2009 [44]. This may have
biased the results in favor of the “aggressive strategy” (i.e., high
compliance rate) because its outcome data were derived from
more recent studies (as opposed to data from older studies for the
V A L U E I N H E A L T H 1 8 ( 2 0 1 5 ) 7 2 1 – 7 3 4732“routine care” and “comfort care” strategies), which reﬂect more
contemporary care and perhaps better overall outcomes inde-
pendent of compliance with the BTF guidelines. Although the
authors of economic evaluations of alternative structures of TBI
care adjusted for differences in case-mix in the original cohorts,
there is still a high risk of unmeasured confounding on each
study’s ﬁndings [18,29]. Moreover, these studies did not account
for the implementation and maintenance costs of alternative
structures of care (e.g., cost of establishing and maintaining a
Physician-staffed Helicopter Emergency Medical Services Pro-
gram), which may have overestimated the economic attractive-
ness of these alternative settings of care [18,29]. Finally, because
these studies were conducted in speciﬁc health care settings,
their results may not be generalizable to other health care
systems with different economic conditions.
We used an extensive and well-deﬁned search strategy that
encompassed multiple electronic databases and the gray liter-
ature to identify relevant economic evaluations. Furthermore,
two reviewers independently applied the inclusion criteria and
assessed the quality of the included studies using a structured
appraisal tool developed by an international and multidiscipli-
nary team of experts in economic evaluation methodology
[15,16]. In addition to the structured quality assessment of
contemporary economic evaluations using a generic instrument,
we highlighted a number of methodological aspects speciﬁc to
the population with TBI, which can help to improve future study
design.
The number of economic evaluations in the diagnosis and
management of TBI has increased over the past decade. Most of
the studies, however, are still of low to moderate quality. Only 3
of 24 studies derived clinical effectiveness estimates from RCTs
[28,39,40], with the remainder based on retrospective observatio-
nal data. Although the functional, cognitive, social, and economic
effects of TBI are lifelong, most of these economic evaluations did
not use a lifetime horizon when comparing costs and conse-
quences of alternative strategies. Among the studies that con-
sidered the lifetime horizon, most assumed that functional
outcomes were ﬁxed 6 to 18 months following TBI. This assump-
tion runs contrary to ﬁndings from previous follow-up studies,
which suggest that functional outcomes of patients with TBI
evolve considerably beyond the ﬁrst few years postinjury [42].
Because of the substantial and lifelong impact of TBI, eco-
nomic evaluations of TBI diagnostic or management strategies
should incorporate a lifetime horizon when evaluating costs and
consequences. Although previous studies have attempted to
characterize the long-term natural history of TBI, these studies
were of limited quality because of the small sample sizes, high
dropout rates, short follow-up times, and/or the combination of
patients with heterogeneous injuries [42,43,45,46]. Mild, moder-
ate, and severe TBI differ greatly in expected recovery and
outcomes, and may present as different diseases [47]. Therefore,
the duration, natural history, and life course manifestations of
mild, moderate, and severe TBI should be characterized in large
longitudinal studies that evaluate each TBI category separately.
Better characterization of TBI natural history can help avoid
making strong assumptions about the trajectory of recovery of
patients with TBI in future economic evaluations.
Previous cost-utility studies were limited by the scarce num-
ber of utility-measurement studies that examined the long-term
health states speciﬁc to the TBI population [18,21]. Among cost-
utility analyses (n ¼ 9), four studies [19,22,23,25] derived their
utility scores for the GOS categories from the study by Aoki et al.
[41]. The latter investigators used the standard gamble technique
to estimate utility scores for long-term health states among
patients with subarachnoid hemorrhage, using a convenience
sample of health care workers (n ¼ 140) at a hospital in Japan [41].
Two studies [20,21] used GOS utility scores provided by Smitset al. [21] cohort, in which long-term GOS outcomes and their
utility scores (using the EuroQol ﬁve-dimensional questionnaire)
were measured in a subset of patients with mild TBI (n ¼ 87;
which represents 28% of the original sample) from the CT in head
injury patients study [48,49]. None of the included studies
considered utility scores for short-term health states (i.e., health
states during the ﬁrst 6 months postinjury). Short-term health
states should be accounted for when calculating quality-adjusted
life expectancy in the TBI population. Although accounting for
such temporary states may not substantially affect the overall
quality-adjusted life expectancy of patients with long life expect-
ancy (e.g., young patients who have good functional recovery),
the quality of life during these health states may signiﬁcantly
affect the quality-adjusted life expectancy calculation for older
patients and for patients with poor functional recovery because
these short-term states likely constitute a major portion of the
relatively short life expectancy of these patients. Collectively,
these two patient groups represent a large proportion of the
population with TBI. Furthermore, discounting future costs and
consequences tends to disproportionately weight acute and
subacute health states relative to long-term states, which also
highlights the importance of accounting for short-term health
states. It is plausible that certain long-term health states follow-
ing TBI (e.g., persistent vegetative state) could be perceived as
worse than death by patients, their families, caregivers, and/or
society. Future utility-measurement studies should consider this
possibility and allow for negative utility scores (i.e., worse than
utility score for death) when measuring preferences for health
states among patients with TBI.
To reﬁne cost calculations in future studies, certain cost
elements require special consideration. The cost of care at
nursing homes and assisted living represents a major cost driver
in TBI economic evaluations, particularly for severely injured
patients [25]. Future studies are indicated to highlight the
variability in this cost component between jurisdictions, varia-
bility in the proportion of patients with TBI who require skilled
nursing care over time, and strategies to improve the efﬁciency of
long-term care programs for TBI survivors. In addition, family
members of TBI survivors suffer a great deal of personal health
and ﬁnancial difﬁculties [50,51]. To optimize economic evalua-
tions that consider costs from a societal perspective, further
investigations are needed to quantify the contribution of costs
of medical care for families of TBI survivors and their lost
productivity to the overall economic burden of TBI on society.
To help prioritize research funding, future economic evalua-
tions in the population with TBI may consider conducting
expected value of perfect information (EVPI) and partial EVPI
analyses to quantify the differential cost of multiple sources of
uncertainty in the evidence base [52]. EVPI is the expected beneﬁt
in monetary terms per patient of a hypothetical study that would
eliminate all parameter uncertainty (or uncertainty in certain
parameters of interest in the case of partial EVPI). More research
is justiﬁed if the expected beneﬁt to future patients (estimated as
the product of EVPI per patient and the population that is
expected to beneﬁt from future research) exceeds the cost of
proposed research [53]. Such analyses may help to focus
future TBI research funding on uncertainty areas with the
highest value.
Lu et al. [54] recently reviewed economic evaluations in TBI.
Our study, however, involved a more comprehensive search of
the literature. In contrast to Lu et al., two reviewers conducted
a more rigorous and detailed quality assessment of included
studies using Consolidated Health Economic Evaluation
Reporting Standards guidelines. In addition, we provide a sum-
mary of results from high-quality economic evaluations and
highlight methodological aspects speciﬁc to the population
with TBI.
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Threshold-guided CT scanning, adherence to BTF guidelines, and
care for patients in specialized settings appear to be economically
attractive strategies among patients with TBI. Most of the
economic evaluations to date, however, are of modest quality.
To better inform future economic evaluations, further methodo-
logically rigorous studies are needed to characterize the natural
history, quality of life, and utility estimates for short-term and
long-term health states among patients with TBI.Acknowledgment
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